Cargando…

People engaged in opioid agonist treatment as a counterpublic during the COVID‐19 pandemic in Australia: A qualitative study

INTRODUCTION: People receiving opioid agonist treatment (OAT) are at higher risk of comorbidities, poverty and discrimination, which Big Events like the COVID‐19 pandemic may exacerbate. The behaviours of people receiving OAT do not always align with normative behaviours as conceived by ruling insti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conway, Anna, Treloar, Carla, Crawford, Sione, Grebely, Jason, Marshall, Alison D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538012/ https://www.ncbi.nlm.nih.gov/pubmed/36054577 http://dx.doi.org/10.1111/dar.13531

Ejemplares similares

Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study
por: Conway, Anna, et al.
Publicado: (2023)

“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic
por: Conway, Anna, et al.
Publicado: (2023)

(Dis)Engagement with queer counterpublics: Exploring intimate and family lives in online and offline spaces in China
por: Lo, Iris Po Yee
Publicado: (2021)

Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia
por: Larance, Briony, et al.
Publicado: (2020)

A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study
por: Conway, Anna, et al.
Publicado: (2022)

Health-related quality of life among people who inject drugs in Australia
por: Cheng, Qinglu, et al.
Publicado: (2023)

Hepatitis B‐related stigma among Chinese immigrants living with hepatitis B virus in Australia: A qualitative study
por: Jin, Defeng, et al.
Publicado: (2022)

Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia
por: Madden, Annie, et al.
Publicado: (2018)

COVID‐19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews
por: Price, Olivia, et al.
Publicado: (2022)

Estimating the number of people who inject drugs in Australia
por: Larney, Sarah, et al.
Publicado: (2017)

Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta‐analysis
por: Ferraro, Claire F., et al.
Publicado: (2021)

Mortality in the SuperMIX cohort of people who inject drugs in Melbourne, Australia: a prospective observational study
por: Hill, Penelope L., et al.
Publicado: (2022)

Health workers’ perspectives of hepatitis B-related stigma among Aboriginal and Torres Strait Islander people in New South Wales, Australia
por: Cama, Elena, et al.
Publicado: (2023)

Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C‐SCOPE Study
por: Litwin, Alain H., et al.
Publicado: (2019)

Cardiovascular disease risk prediction in older people: a qualitative study
por: Taylor, Denise Ann, et al.
Publicado: (2021)

Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy
por: Moallef, Soroush, et al.
Publicado: (2022)

A qualitative study trialling the acceptability of new hepatitis C prevention messages for people who inject drugs: symbiotic messages, pleasure and conditional interpretations
por: Treloar, Carla, et al.
Publicado: (2015)

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
por: Bharat, Chrianna, et al.
Publicado: (2022)

How Do People With Intellectual Disability Engage With and Understand Gambling? A Qualitative Study of Adults in Victoria, Australia
por: Pitt, Hannah, et al.
Publicado: (2021)

A qualitative exploration of young people’s mental health needs in rural and regional Australia: engagement, empowerment and integration
por: Klinner, Christiane, et al.
Publicado: (2023)

Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia
por: Yousafzai, Mohammad T., et al.
Publicado: (2022)

Modeling the population‐level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia
por: Chaillon, Antoine, et al.
Publicado: (2021)

Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000‐2014)
por: Waziry, Reem, et al.
Publicado: (2017)

Addressing injecting related risks among people who inject both opioids and stimulants: Findings from an Australian survey of people who inject drugs
por: Brener, L., et al.
Publicado: (2021)

A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia’s prisons
por: Lafferty, Lise, et al.
Publicado: (2018)

Evaluation of an online injecting drug use stigma intervention targeted at health providers in New South Wales, Australia
por: Brener, Loren, et al.
Publicado: (2017)

The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: findings from the OATS retrospective linkage study.
por: Jones, Nicola, et al.
Publicado: (2022)

Young Aboriginal people’s engagement with STI testing in the Northern Territory, Australia
por: Bell, Stephen, et al.
Publicado: (2020)

Patients’ Perspectives on Coming Off Opioid Agonist Treatment: A Qualitative Study
por: Nehlin, Christina, et al.
Publicado: (2022)

Opioid Agonist Therapies and Pregnancy Outcomes for Pregnant People With Opioid Use Disorder: Protocol for a Systematic Review
por: Wilson, Lindsay A, et al.
Publicado: (2023)

Better agonist for the opioid receptors
por: Badshah, Syed Lal, et al.
Publicado: (2018)

Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment
por: Marchand, Kirsten, et al.
Publicado: (2020)

Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study
por: Galarneau, Lexis R., et al.
Publicado: (2021)

Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England
por: Aldabergenov, D, et al.
Publicado: (2022)

The influence of poly-drug use patterns on the association between opioid agonist treatment engagement and injecting initiation assistance
por: Meyers-Pantele, Stephanie A., et al.
Publicado: (2022)

Opioid agonist and antagonist use and the gut microbiota: associations among people in addiction treatment
por: Gicquelais, Rachel E., et al.
Publicado: (2020)

Prospective study of retention in opioid agonist treatment and contact with emergency healthcare following release from prisons in Victoria, Australia
por: Curtis, Michael, et al.
Publicado: (2023)

COVID-19 and the health of people who use drugs: What is and what could be?
por: Grebely, Jason, et al.
Publicado: (2020)

Evaluation of an integrated care service facility for people living with hepatitis C in New Zealand
por: Horwitz, Robyn, et al.
Publicado: (2012)

Patients’ perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study
por: Scott, Gemma, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_58a2tmim3omn0mrvqr8m5tvgk8